https://www.news-medical.net/news/20221219/Inhibiting-inflammatory-signaling-pathway-could-reduce-the-chances-of-heart-disease-in-cancer-survivors.aspx
Researchers at Memorial Sloan Kettering Cancer Center (MSKCC) in New York have discovered that common cancer treatments, such as radiotherapy or anthracycline drugs, cause long-term damage to heart tissue by activating a key inflammatory signaling pathway.
Create an account or login to join the discussion